Li Jiang
Li Jiang

Li Jiang

Partner

Hong Kong

+852 2846 8915 | +852 9820 2260
Li.Jiang@ashurstperkins.com

Introduction

Li is well known for her business acumen and demonstration of a deep understanding of capital markets regulatory regimes.

Li Jiang is a partner in our corporate transactions practice. Li's practice focuses on international capital markets and corporate transactions. She has extensive experience advising corporates and investment banks on Rule 144A and Regulation S securities offerings, including listings on the Hong Kong Stock Exchange, as well as share placings and secondary offerings throughout Asia. In addition, she regularly advises Hong Kong Stock Exchange-listed companies on ongoing capital markets and compliance matters.

Li received her Juris Doctor degree, magna cum laude, from Washington University School of Law. She received her Master's degree in Economics from the University of Pennsylvania and Bachelor's degree in Economics & Finance from the University of Hong Kong.

Li is a native speaker of Mandarin and speaks fluent English and Cantonese.

Li is qualified in the state of New York and is admitted as a solicitor in Hong Kong.

  • Fujian Haixi Pharmaceuticals | Represented client, a commercial-stage pharmaceutical company that integrates R&D, production and sales capacities, with a pipeline of innovative drug candidates, on its HK$993.6 million Hong Kong IPO and global offering pursuant to Chapter 18A. Huatai Financial Holding and CMB International acted as the joint sponsors.
  • Shanghai Voicecomm Information Technology Co. Ltd., | Represented client, a Chinese enterprise-level information technology solutions provider, on its HK$571.6m Hong Kong IPO and global offering. CICC is the sole sponsor. The first conversational AI software company listed in Hong Kong.
  • UBS and Essence | Represented clients as the joint sponsors and underwriters on the HK$212m Hong Kong IPO and global offering of Shandong Boan Biotechnology pursuant to Chapter 18A and its spinoff listing on the Hong Kong Stock Exchange from Luye Pharma.
  • CCB International and Huatai Financial Holding as the joint sponsors on the HK$611.9m Hong Kong IPO and global offering of Cloudbreak Pharma, a biotechnology company dedicated to the development of novel and differentiated ophthalmology treatments.
  • Xizang Zhihui Mining Co., Ltd. | Represented client, a mining company focusing on zinc, lead and copper exploration, mining, production and sales of concentrates based in Xizang, China, on its HK$550m Hong Kong IPO and global offering. Sinolink Securities (Hong Kong) and Maxa Capital acted as joint sponsors.
  • ICBC International | Represented client as the sole sponsor on the HK$586.3m Hong Kong IPO and global offering of Hanx Biopharmaceuticals, a Wuhan-based biopharmaceutical company focused on innovative therapy R&D, with operations covering drug discovery, clinical development and manufacturing.
  • CITICS and Haitong | Represented clients as the joint sponsors and underwriters the on the HK$781.8m Hong Kong IPO and global offering of Butong Group, a China-based consumer product company focused on the design, manufacture, and sale of premium nursery products under the BeBeBus brand, targeting middle to high-end consumers
  • Luye Pharma | Represented client on its US$760m Hong Kong IPO. UBS, Citi and CITIC Securities acted as joint sponsors. The world's largest listing of the year in the pharmaceutical sector; awarded Best Equity Deal in China by IFLR Asia Awards 2014.
  • CIMB Investment Bank and RHB Investment Bank | Represented client in relation to the US$160m Malaysian IPO of Sona Petroleum. Sona Petroleum is a Malaysia-based company engaged in the exploration and acquisition of oil and gas deposits in Asia and African countries.
  • Far East Consortium | Represented client on its £95.7m acquisition of R&F Properties VS (UK) Co., Ltd., owning the 133,000 sqm gross floor area mixed use development site at Vauxhall Square in Vauxhall, London.

Latest thinking

Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.

Latest news, deals and awards

Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.